Cardiovascular Medicine

Peripheral Artery Disease and COVID-19 Outcomes: Insights from the Yale DOM-CovX Registry

1. Kim G. Smolderen
2. Megan Lee
3. Tanima Arora
4. Michael Simonov
5. Carlos Mena-Hurtado

Reviewed by ScreenIT

HIF1alpha Cardioprotection in COVID-19 Patients

1. Bingyan J. Wang
2. Sangeetha Vadakke-Madathil
3. Lori B. Croft
4. Rachel I. Brody
5. Hina W. Chaudhry

Reviewed by ScreenIT

Echocardiographic characterisation in critical Covid19 - an observational study

1. Henrik Isackson
2. Anders Larsson
3. Miklos Lipcsey
4. Robert Frithiof
5. Frank A. Flachskampf
6. Michael Hultström

Reviewed by ScreenIT

Influenza infection, Acute myocardial Infarction, Flu Shot during COVID-19 Pandemic in US population. A Review of Literature

1. Nischit Baral
2. Nirajan Nayak

Reviewed by ScreenIT

Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

1. Kamal Matli
2. Nibal Chamoun
3. Aya Fares
4. Victor Zibara
5. Soad Al-Osta
6. Rabih Nasrallah
7. Pascale Salameh
8. Jacques Mokhbat
9. Georges Ghanem

Reviewed by ScreenIT

Plasma P ‐selectin is an early marker of thromboembolism in COVID ‐19

1. Bánk G. Fenyves
2. Arnav Mehta
3. MGH COVID‐19 Collection & Processing Team
4. Kyle R. Kays
5. Caroline Beakes
6. Justin Margolin
7. Marcia B. Goldberg
8. Nir Hacohen
9. Michael R. Filbin

Reviewed by ScreenIT

Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients after COVID-19

1. Michał Chudzik
2. Monika Burzyńska
3. Joanna Kapusta

Reviewed by ScreenIT

Aorta smooth muscle-on-a-chip reveals impaired mitochondrial dynamics as a therapeutic target for aortic aneurysm in bicuspid aortic valve disease

1. Mieradilijiang Abudupataer
2. Shichao Zhu
3. Shiqiang Yan
4. Kehua Xu
5. Jingjing Zhang
6. Shaman Luo
7. Wenrui Ma
8. Md Fazle Alam
9. Yuyi Tang
10. Hui Huang
11. Nan Chen
12. Li Wang
13. Guoquan Yan
14. Jun Li
15. Hao Lai
16. Chunsheng Wang
17. Kai Zhu
18. Weijia Zhang

• Curated by eLife

  Evaluation Summary:

  The authors developed an aorta-on-a-chip system to investigate the potential mechanism of Bicuspid Aortic Valve-Thoracic Aortic Aneurysm, BAV-TAA, and to test candidate pharmacologic agents. This study is of broad interest to readers in the field of lab-on-a-chip, biomedicine, biomaterials, etc. However, some important details regarding the development of the model are missing, as are some control data. The authors need to discuss the limitations of this model, such as the inability of their on-a-chip model to recapitulate aortic changes associated with complex pathologic processes such as ECM degradation, inflammation, etc, and discuss the importance of follow-up studies in in vivo models.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. The reviewers remained anonymous to the authors.)

Reviewed by eLife

Anticoagulants and Antiplatelets in COVID-19: Impact on Survival and Thromboembolism Development

1. Thomas Salmon
2. Mitchell Titley
3. Zaid Noori
4. Mark Crosby
5. Rajiv Sankaranarayanan

Reviewed by ScreenIT

TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy

1. Gert Jacobus Laubscher
2. Petrus Johannes Lourens
3. Chantelle Venter
4. Douglas B Kell
5. Etheresia Pretorius

Reviewed by ScreenIT